These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 39069865

  • 1. [Preliminary clinical use of hepatic arterial infusion chemotherapy combined with lenvatinib and tislelizumab in the treatment of unresectable intrahepatic cholangiocarcinoma].
    Zhou BJ, Wang WS, Yin Y, Yang J, Zhu XL, Ni CF.
    Zhonghua Nei Ke Za Zhi; 2024 Aug 01; 63(8):769-775. PubMed ID: 39069865
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of lenvatinib plus durvalumab combined with hepatic arterial infusion chemotherapy for unresectable intrahepatic cholangiocarcinoma.
    Zhao R, Zhou J, Miao Z, Xiong X, Wei W, Li S, Guo R.
    Front Immunol; 2024 Aug 01; 15():1397827. PubMed ID: 38799453
    [Abstract] [Full Text] [Related]

  • 4. Efficacy analysis of HAIC combined with lenvatinib plus PD1 inhibitor vs. first-line systemic chemotherapy for advanced intrahepatic cholangiocarcinoma.
    Lin Z, Zou X, Hu X, Huang D, Chen Y, Lin J, Li X, Zhang J.
    Sci Rep; 2024 Oct 14; 14(1):23961. PubMed ID: 39397104
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hepatic arterial infusion of gemcitabine plus oxaliplatin as second-line treatment for locally advanced intrahepatic cholangiocarcinoma: preliminary experience.
    Ghiringhelli F, Lorgis V, Vincent J, Ladoire S, Guiu B.
    Chemotherapy; 2013 Oct 14; 59(5):354-60. PubMed ID: 24821200
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Analysis of the efficacy and safety of hepatic arterial infusion chemotherapy for unresectable hepatitis B-related intrahepatic cholangiocarcinoma].
    He MR, Zheng ZK, Wu TQ, Chen MS, Zhou ZG.
    Zhonghua Wai Ke Za Zhi; 2024 Apr 01; 62(4):309-315. PubMed ID: 38432672
    [Abstract] [Full Text] [Related]

  • 10. Chemotherapy combined with lenvatinib and PD-1 may be a potential better alternative option for advanced unresectable intrahepatic cholangiocarcinoma: a retrospective real-world study.
    Dong Z, Sui C, Lu J, Guo J, Duan K, Wang K, Geng L, Dai B, Yang J.
    Front Immunol; 2024 Apr 01; 15():1463574. PubMed ID: 39290704
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of tislelizumab plus lenvatinib as first-line treatment in patients with unresectable hepatocellular carcinoma: a multicenter, single-arm, phase 2 trial.
    Xu L, Chen J, Liu C, Song X, Zhang Y, Zhao H, Yan S, Jia W, Wu Z, Guo Y, Yang J, Gong W, Ma Y, Yang X, Gao Z, Zhang N, Zheng X, Li M, Su D, Chen M.
    BMC Med; 2024 Apr 23; 22(1):172. PubMed ID: 38650037
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness, safety, and biomarker analysis of lenvatinib plus toripalimab as chemo-free therapy in advanced intrahepatic cholangiocarcinoma: a real-world study.
    Wang S, Chao J, Wang H, Li S, Wang Y, Zhu C, Zhang N, Piao M, Yang X, Liu K, Xun Z, Sang X, Yang X, Duan W, Zhao H.
    Cancer Immunol Immunother; 2024 Oct 03; 73(12):249. PubMed ID: 39358645
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hepatic artery infusion chemotherapy with systemic capecitabine and camrelizumab for treating unresectable hilar cholangiocarcinoma: An initial investigation of efficacy and safety.
    Li L, Liu S, Wang Q, Wang Y, Yu G.
    J Cancer Res Ther; 2024 Apr 01; 20(2):578-583. PubMed ID: 38687927
    [Abstract] [Full Text] [Related]

  • 16. Potential efficacy of hepatic arterial infusion chemotherapy using gemcitabine, cisplatin, and 5-fluorouracil for intrahepatic cholangiocarcinoma.
    Ishii M, Itano O, Morinaga J, Shirakawa H, Itano S.
    PLoS One; 2022 Apr 01; 17(4):e0266707. PubMed ID: 35452492
    [Abstract] [Full Text] [Related]

  • 17. Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein-1 inhibitors: A promising treatment approach for high-burden hepatocellular carcinoma.
    Fu S, Xu Y, Mao Y, He M, Chen Z, Huang S, Li D, Lv Y, Wu J.
    Cancer Med; 2024 May 01; 13(9):e7105. PubMed ID: 38686567
    [Abstract] [Full Text] [Related]

  • 18. Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
    Cercek A, Boerner T, Tan BR, Chou JF, Gönen M, Boucher TM, Hauser HF, Do RKG, Lowery MA, Harding JJ, Varghese AM, Reidy-Lagunes D, Saltz L, Schultz N, Kingham TP, D'Angelica MI, DeMatteo RP, Drebin JA, Allen PJ, Balachandran VP, Lim KH, Sanchez-Vega F, Vachharajani N, Majella Doyle MB, Fields RC, Hawkins WG, Strasberg SM, Chapman WC, Diaz LA, Kemeny NE, Jarnagin WR.
    JAMA Oncol; 2020 Jan 01; 6(1):60-67. PubMed ID: 31670750
    [Abstract] [Full Text] [Related]

  • 19. Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial.
    Malka D, Cervera P, Foulon S, Trarbach T, de la Fouchardière C, Boucher E, Fartoux L, Faivre S, Blanc JF, Viret F, Assenat E, Seufferlein T, Herrmann T, Grenier J, Hammel P, Dollinger M, André T, Hahn P, Heinemann V, Rousseau V, Ducreux M, Pignon JP, Wendum D, Rosmorduc O, Greten TF, BINGO investigators.
    Lancet Oncol; 2014 Jul 01; 15(8):819-28. PubMed ID: 24852116
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitors for advanced hepatocellular carcinoma with macrovascular invasion.
    Zhang Y, Zhang H, Xu H, Wang Y, Feng L, Yi F.
    World J Surg Oncol; 2024 May 06; 22(1):122. PubMed ID: 38711095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.